These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 34272384)
1. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Prekovic S; Schuurman K; Mayayo-Peralta I; Manjón AG; Buijs M; Yavuz S; Wellenstein MD; Barrera A; Monkhorst K; Huber A; Morris B; Lieftink C; Chalkiadakis T; Alkan F; Silva J; Győrffy B; Hoekman L; van den Broek B; Teunissen H; Debets DO; Severson T; Jonkers J; Reddy T; de Visser KE; Faller W; Beijersbergen R; Altelaar M; de Wit E; Medema R; Zwart W Nat Commun; 2021 Jul; 12(1):4360. PubMed ID: 34272384 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer. West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357 [No Abstract] [Full Text] [Related]
4. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells. An BC; Jung NK; Park CY; Oh IJ; Choi YD; Park JI; Lee SW Mol Cells; 2016 Aug; 39(8):631-8. PubMed ID: 27484907 [TBL] [Abstract][Full Text] [Related]
5. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells. Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691 [TBL] [Abstract][Full Text] [Related]
6. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo. Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175 [TBL] [Abstract][Full Text] [Related]
7. SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids. Stubbs FE; Birnie MT; Biddie SC; Lightman SL; Conway-Campbell BL Mol Cell Endocrinol; 2018 Feb; 461():226-235. PubMed ID: 28942102 [TBL] [Abstract][Full Text] [Related]
8. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834 [TBL] [Abstract][Full Text] [Related]
9. Interaction of the glucocorticoid receptor with the chromatin landscape. John S; Sabo PJ; Johnson TA; Sung MH; Biddie SC; Lightman SL; Voss TC; Davis SR; Meltzer PS; Stamatoyannopoulos JA; Hager GL Mol Cell; 2008 Mar; 29(5):611-24. PubMed ID: 18342607 [TBL] [Abstract][Full Text] [Related]
10. The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer. Jangani M; Poolman TM; Matthews L; Yang N; Farrow SN; Berry A; Hanley N; Williamson AJ; Whetton AD; Donn R; Ray DW J Biol Chem; 2014 Mar; 289(13):8931-46. PubMed ID: 24488492 [TBL] [Abstract][Full Text] [Related]
11. Multimodal regulatory elements within a hormone-specific super enhancer control a heterogeneous transcriptional response. Hoffman JA; Trotter KW; Day CR; Ward JM; Inoue K; Rodriguez J; Archer TK Mol Cell; 2022 Feb; 82(4):803-815.e5. PubMed ID: 35077705 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes. Wang H; Duan A; Zhang J; Wang Q; Xing Y; Qin Z; Liu Z; Yang J Commun Biol; 2021 Jun; 4(1):675. PubMed ID: 34083716 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. Lu YS; Lien HC; Yeh PY; Kuo SH; Chang WC; Kuo ML; Cheng AL Lung Cancer; 2006 Sep; 53(3):303-10. PubMed ID: 16806572 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915 [TBL] [Abstract][Full Text] [Related]
16. How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids. Strickland BA; Ansari SA; Dantoft W; Uhlenhaut NH FEBS Lett; 2022 Oct; 596(20):2596-2616. PubMed ID: 35612756 [TBL] [Abstract][Full Text] [Related]
17. Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids. D'Ippolito AM; McDowell IC; Barrera A; Hong LK; Leichter SM; Bartelt LC; Vockley CM; Majoros WH; Safi A; Song L; Gersbach CA; Crawford GE; Reddy TE Cell Syst; 2018 Aug; 7(2):146-160.e7. PubMed ID: 30031775 [TBL] [Abstract][Full Text] [Related]
18. Chronic p27 Patki M; McFall T; Rosati R; Huang Y; Malysa A; Polin L; Fielder A; Wilson MR; Lonardo F; Back J; Li J; Matherly LH; Bepler G; Ratnam M Sci Rep; 2018 Oct; 8(1):16006. PubMed ID: 30375484 [TBL] [Abstract][Full Text] [Related]
19. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Gummow BM; Scheys JO; Cancelli VR; Hammer GD Mol Endocrinol; 2006 Nov; 20(11):2711-23. PubMed ID: 16857744 [TBL] [Abstract][Full Text] [Related]
20. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression. Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]